GLOBAL LEADERS
IN THE PROTEIN ENGINEERING
OF IgM ANTIBODIES

Multimeric Anti-DR5 IgM antibody displays potent cytotoxicity in vitro and promotes tumor regression in vivo. 

High Avidity Anti-CD20 IgM Antibody for Enhanced Complement-Dependent Cell Killing of Low CD20 Expressing Tumor Cells. View the full poster here (623 Kb PDF)

IGM-55.5, a novel monoclonal human recombinant IgM antibody with potent activity against B cell leukemia and lymphoma. View the full poster here. (940Kb PDF)